Is there too much reliance on computers to detect plagiarism?
Plagiarism detection software and the originality scores they generate are useful, but find out why human input is a fundamental part of the process.
Five essential factors for data sharing
Discover the five areas for improvement identified in Springer Nature’s recent surveys of researchers, aiming to promote data sharing.
Statisticians revolt against the concept of ‘statistical significance’
Statisticians and over 800 signatories challenge the concept of ‘statistical significance’, calling for an end to overstated claims and missed discoveries.
Meeting report: summary of day 3 of the 2019 ISMPP Annual Meeting
Missed the 15th Annual Meeting of ISMPP? Read our meeting report to get up to speed!
Open access and Plan S: what do key stakeholders think?
ISMPP’s first white paper, ‘A multistakeholder discussion on open access and medical publishing’ is now available.
Meeting report: summary of day 2 of the 2019 ISMPP Annual Meeting
Missed the 15th Annual Meeting of ISMPP? Read our meeting report to get up to speed!
Meeting report: summary of day 1 of the 2019 ISMPP Annual Meeting
Missed the 15th Annual Meeting of ISMPP? Read our meeting report to get up to speed!
Are ‘funding body journals’ the future of scientific publishing?
A recent article from The Chronicle of Higher Education discusses the potential benefits associated with journals that are established by funding bodies.
Tracking innovations in peer review
Discover how to track the proliferation of initiatives aimed at improving the peer review process.
Public feedback to shape Plan S implementation guidance
Feedback on the implementation guidance for Plan S highlights key themes for consideration.
World Health Day 2019: promoting universal health coverage
Find out how we can all work towards universal health coverage this World Health Day to help achieve the WHO’s goal of #HealthForAll.
The challenges of rare disease publication planning
Discover how to develop an effective publications strategy for rare diseases with a recent article from the MAP newsletter.
Should pharmaceutical companies be doing more to advocate open access?
Many public funders have mandated open access to their research and support Plan S. Should pharmaceutical companies follow suit?
Disparities claimed between stance and action on clinical trial outcome reporting by top medical journals
Selective reporting of clinical trial outcomes may be widespread. This study reports instances occurring in CONSORT-endorsing medical journals.
It’s time to increase awareness of data ‘FAIRness’
Are you familiar with the FAIR data principles? Find out how to boost your data’s usefulness by making your data FAIR: Findable, Accessible, Interoperable, and Reusable.
Self-citation by peer reviewers: when is it appropriate and how to safeguard against malpractice
Authors and editors are asked to be vigilant, and advice to peer reviewers is updated, amidst scandal of reviewer who asked for multiple self-citations during reviews.